Physician

Hematology

Dr. Edward R. Arrowsmith, MD

Edward Arrowsmith practices Hematology. He studied medicine at Vanderbilt University School of Medicine. He received awards:"CMS Meaningful Use Stage 1 Certification". Edward Arrowsmith has written publications. He has 14 publications published with PubMed. The lastest publication is: 'Advanced-practice nursing--good medicine for physicians?' Edward R. Arrowsmith accepts Medicare payments and is listed with Medicare.gov.

Publications

Phase I/II Study of the Combination of Panobinostat and Carfilzomib in Patients with Relapsed/Refractory Multiple Myeloma.
Everolimus in combination with paclitaxel and carboplatin in patients with metastatic melanoma: a phase II trial of the Sarah Cannon Research Institute Oncology Resear...
Pazopanib as Second-Line Treatment After Sunitinib or Bevacizumab in Patients With Advanced Renal Cell Carcinoma: A Sarah Cannon Oncology Research Consortium Phase II ...
High-Dose Bevacizumab in the Treatment of Patients With Advanced Clear Cell Renal Carcinoma: A Phase II Trial of the Sarah Cannon Oncology Research Consortium.
A Phase II Study of Higher Dose Weekly Topotecan in Relapsed Small-Cell Lung Cancer.
Phase II Study of Bevacizumab and Chemoradiation in the Preoperative or Adjuvant Treatment of Patients With Stage II/III Rectal Cancer.
Age and cytogenetics as predictors of event free survival in patients with acute non-lymphocytic leukemia receiving high dose cytosine arabinoside and daunorubicin as ...
Hormonal therapy plus bevacizumab in postmenopausal patients who have hormone receptor-positive metastatic breast cancer: a phase II Trial of the Sarah Cannon Oncology...
Peripheral T-cell lymphomas: clinical features and prognostic factors of 92 cases defined by the revised European American lymphoma classification.
A phase II trial of panobinostat, a histone deacetylase inhibitor, in the treatment of patients with refractory metastatic renal cell carcinoma.
Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemia.
Advanced-practice nursing--good medicine for physicians?
Progressive dyspnea and weight loss.

Schools

Vanderbilt University
Vanderbilt University Med Center

Procedures Preformed

Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
Plasmapheresis
Thoracentesis

Doctors Specialties

Oncology
Hematology

Accepted Insurances

Awards

CMS Meaningful Use Stage 1 Certification

Education

Vanderbilt University
Vanderbilt University School of Medicine

Drug Facts

NPI NUMBER		1780632687
NPPES Provider LastName		ARROWSMITH
NPPES Provider FirstName		EDWARD
NPPES Provider ZIPCode		374041130
NPPES Provider State		TN
Specialty Description		Hematology/Oncology
Total Claim Count		1394.0
Distinct Opioid Count		9.0
Opioid Claim Count		254.0
Percent Opioid Claims		18.22

Helpful Reviews

Give Anonymous Review

Medicare Facts

National Provider Identifier [NPI]	1780632687
Last Name Of The Provider	ARROWSMITH
First Name Of The Provider	EDWARD
View All

Similar Doctors

	Dr. Robert M. Graham, MD This Doctor is OpenDoctor Recommended.
	Dr. Derek W. Holland, MD This Doctor is OpenDoctor Recommended.
	Dr. Davey B. Daniel, MD This Doctor is OpenDoctor Recommended.
	Dr. Sylvia L. Krueger, MD This Doctor is OpenDoctor Recommended.
	Dr. Vaishali Doshi, MD This Doctor is OpenDoctor Recommended.
	Dr. Russell A. Jones, MD This Doctor is OpenDoctor Recommended.
	Dr. Darrell R. Johnson, MD This Doctor is OpenDoctor Recommended.
	Dr. Chunhui Fang, MD This Doctor is OpenDoctor Recommended.